$ABT stock has now fallen 3% today, according to our price data from Polygon. There has been approximately $623,058,469 of trading volume.
It has been the 80th most-searched ticker on Quiver Quantitative over the last day, out of 12,885 total tickers searched.
Here is what we see in our data on $ABT (you can track the company live on Quiver's $ABT stock page):
$ABT Insider Trading Activity
$ABT insiders have traded $ABT stock on the open market 10 times in the past 6 months. Of those trades, 3 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $ABT stock by insiders over the last 6 months:
- ROBERT B FORD (CHAIRMAN AND CEO) purchased 18,800 shares for an estimated $2,013,966
- DANIEL J STARKS has made 2 purchases buying 10,000 shares for an estimated $1,087,331 and 0 sales.
- ERIC SHROFF (Senior Vice President) has made 0 purchases and 2 sales selling 2,295 shares for an estimated $284,988.
- LOUIS H. MORRONE (EXECUTIVE VICE PRESIDENT) sold 1,144 shares for an estimated $132,223
- DANIEL GESUA SIVE SALVADORI (EVP AND GROUP PRESIDENT) sold 885 shares for an estimated $102,288
- MARY K MORELAND (EXECUTIVE VICE PRESIDENT) sold 613 shares for an estimated $70,850
- JOHN A. JR. MCCOY (VICE PRESIDENT AND CONTROLLER) sold 585 shares for an estimated $67,614
- ELIZABETH C. CUSHMAN (EVP, GC AND SECRETARY) sold 263 shares for an estimated $30,397
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ABT Hedge Fund Activity
We have seen 1,272 institutional investors add shares of $ABT stock to their portfolio, and 1,529 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. STERN & CO. LLP added 39,005,451 shares (+12439.6%) to their portfolio in Q4 2025, for an estimated $4,886,992,955
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 30,767,022 shares (-73.6%) from their portfolio in Q4 2025, for an estimated $3,854,800,186
- JPMORGAN CHASE & CO removed 7,190,072 shares (-24.5%) from their portfolio in Q4 2025, for an estimated $900,844,120
- ALLIANCEBERNSTEIN L.P. added 6,926,031 shares (+125.3%) to their portfolio in Q4 2025, for an estimated $867,762,423
- BLACKROCK, INC. added 5,348,812 shares (+3.8%) to their portfolio in Q4 2025, for an estimated $670,152,655
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 4,993,343 shares (-28.1%) from their portfolio in Q4 2025, for an estimated $625,615,944
- POLEN CAPITAL MANAGEMENT LLC removed 3,458,374 shares (-46.6%) from their portfolio in Q4 2025, for an estimated $433,299,678
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ABT Government Contracts
We have seen $125,314,920 of award payments to $ABT over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- VISN1 BPA FOR IMMUNOCHEMISTRY CPRR TESTING ADDING EQUIPMENT FOR MANCHESTER NH VAMC - WITHIN ORIGINAL SCOPE: $4,335,000
- CHEMISTRY IMMUNOASSAY ANALYZER COST PER REPORTABLE RESULT (CPRR) PRICE SCHEDULE UPDATE: $4,000,483
- LAB CHEMISTRY SERVICES: $3,620,964
- EXERCISING OPTION YEAR 2: $2,600,297
- CHEMISTRY ANALYZERS.: $2,351,823
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$ABT Congressional Stock Trading
Members of Congress have traded $ABT stock 11 times in the past 6 months. Of those trades, 4 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $ABT stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICHARD MCCORMICK has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/19, 11/05 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 11/18 and 2 sales worth up to $30,000 on 02/10, 12/19.
- REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 01/29.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 12/08.
- REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ABT Analyst Ratings
Wall Street analysts have issued reports on $ABT in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 02/02/2026
- BTIG issued a "Buy" rating on 01/23/2026
- RBC Capital issued a "Outperform" rating on 10/16/2025
- Wells Fargo issued a "Overweight" rating on 10/16/2025
- Raymond James issued a "Outperform" rating on 10/16/2025
- Evercore ISI Group issued a "Outperform" rating on 10/16/2025
To track analyst ratings and price targets for $ABT, check out Quiver Quantitative's $ABT forecast page.
$ABT Price Targets
Multiple analysts have issued price targets for $ABT recently. We have seen 11 analysts offer price targets for $ABT in the last 6 months, with a median target of $135.0.
Here are some recent targets:
- David Roman from Goldman Sachs set a target price of $121.0 on 04/09/2026
- Matt Miksic from Barclays set a target price of $144.0 on 04/08/2026
- Vijay Kumar from Evercore ISI Group set a target price of $134.0 on 04/06/2026
- Marie Thibault from BTIG set a target price of $131.0 on 03/31/2026
- Joanne Wuensch from Citigroup set a target price of $136.0 on 03/11/2026
- Adam Maeder from Piper Sandler set a target price of $135.0 on 01/23/2026
- Shagun Singh from RBC Capital set a target price of $135.0 on 01/23/2026
You can track data on $ABT on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
